<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 20 Feb 2021 21:11:55 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>中国医药企协筹备成立“新药研发与注册专业委员会”，程增江将任专委会主任</title><link>https://mp.weixin.qq.com/s/hlNyDSYX5fcsl_UT7jVZGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAKBLN8DaHDia5NibH7aXbVicXE1kHU0gl1OsY4V9mpITUEXYT0KAudajXdx10ftugRpaBjJsnia31DA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>促进我国医药创新能力提升，营造良好的医药创新生态。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item><item><title>​FiercePharma：研究表明，辉瑞/Moderna的COVID-19疫苗对变异体的效力较弱</title><link>https://mp.weixin.qq.com/s/vdAFLxznGIqVpflaE1E2SA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BuUGTtE0JPecyc9H2N4xPdbY1yHVoOkgib77rJ2meByPOOPGltLNCJic2K4qh0CWQaa2N2g42TR7rQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如题。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item><item><title>2021年，这18款创新药有望获美国FDA批准上市</title><link>https://mp.weixin.qq.com/s/9_l5Wn1QRMa7YJBAICz17Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BuUGTtE0JPecyc9H2N4xPdcxbMiaMXleVqia4xfWjHfoSlGw9qHg4qKCAFqluFwBTRciceTstOgm4icA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这些药均已被FDA授予优先审评资格。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item><item><title>Theranostics：工程化外泌体用于药物靶向递送</title><link>https://mp.weixin.qq.com/s/BqkFSL6PtDQsQtsnjfrVQw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BuUGTtE0JPecyc9H2N4xPdIq9guiaASV9scicclhOLm4UfIokJXwpNchxiaCsPZecbStLbgLmTiciaYtw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>外泌体介导的药物递送有望用于多种疾病的无细胞疗法。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item><item><title>浅谈药物共晶制备技术</title><link>https://mp.weixin.qq.com/s/6r1EMKeRAOKgTk-vRwcPdg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CXbhXUFE66H54gibz0BAZAfmNBz8MqgPLzy4GsQ0ltrhRo0dB3h0cM0EWRLMEqLpL7uibHbR1xesqA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>​本文就药物共晶制备技术与筛选方法进行较为全面的论述。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item><item><title>低分子量肝素类药物，为什么说是一种复杂制剂？</title><link>https://mp.weixin.qq.com/s/DNaN3Qr8VNt8Vmqokmql9Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CVKw7sCqke0eRdbWZe5ySrLEne2w1IYDVQ0qcnjODJmkwI9fagVErMulJjfHIqib6LRtzNmDBKehA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有些复杂的制剂需要谨慎对待的，例如低分子量肝素。]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:24:18 +0800</pubDate></item><item><title>写意发布丨全球首个鼻咽癌免疫疗法获批，本土新药特瑞普利单抗为患者带来更长生存获益</title><link>https://mp.weixin.qq.com/s/FBhLHtJcoIdKvL8LhiLqgw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAKBLN8DaHDia5NibH7aXbVicQADBMYr9q2PfMorpMtn8YdBHxNlWSM1SKkdcmFIBBZHZrkxyM5BKjg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>君实生物特瑞普利单抗获批新适应症，填补晚期鼻咽癌治疗空白。]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:24:18 +0800</pubDate></item><item><title>生物类似药政策落地：不能自动外推参照药全部适应症</title><link>https://mp.weixin.qq.com/s/nddeQx9pmA4MOTUBGx1Ktw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAKBLN8DaHDia5NibH7aXbVicB3x2icJvE9NY3k89OLTEuuoq7icN4hrVQsPhDic0A58CejtIrV5JdibdoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国家药品监督管理局药品审评中心官网发布《指导原则》。]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:24:18 +0800</pubDate></item><item><title>能否诞生下一个“PD-1”？实体瘤4个最热靶点16个最快项目！</title><link>https://mp.weixin.qq.com/s/6Ahd8HVnK-IzpjsvOo-HuQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DlsjXiaiavC3tqPmwMyHHS62mGAuUWnSt0LKvkiabJoFYv6weJm63aOP4VHoegU2nbIEfibxC3GOVZcg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>哪些热门靶点有望率先上市？]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:24:18 +0800</pubDate></item><item><title>FDA警告信：慎用同步验证</title><link>https://mp.weixin.qq.com/s/4v9EM9840xVyFkrH7W26FA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAKBLN8DaHDia5NibH7aXbVicBzSYSOyAwXIWsOzkFAlibicFYWibTHraxaYARjquiaP36jhGeibGlR94Zdg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FDA公布一封针对Allay Pharmaceuticals的警告信。]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:24:18 +0800</pubDate></item><item><title>写意报告丨创响王健：千里之行，始于团队</title><link>https://mp.weixin.qq.com/s/zfEG4HRjj7olsZZ33xzGPQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AT5lsHMkso4ib6azGol6AIkUjpOFLays4jEiaG9eiczYfg3M97X3J0GYsOSPAvYKDvKic43ZRKXGXyQQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>成功创业者的L.E.A.P.特质。]]></content:encoded><pubDate>Thu, 18 Feb 2021 19:24:53 +0800</pubDate></item><item><title>2011-2020年10年临床研发成功率及贡献因素</title><link>https://mp.weixin.qq.com/s/qile-T3ANTmeTuZq0AI-lQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CXbhXUFE66H54gibz0BAZAfsIzSye0mPt9X4RCN4maPvhGSTk4Ca4pGvfNGBliaJSRricoO5VTZUnpA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>影响生物制药研发成功要素的较全面的综合分析报告。]]></content:encoded><pubDate>Thu, 18 Feb 2021 19:24:53 +0800</pubDate></item><item><title>写意发布丨君实生物特瑞普利单抗联合化疗用于一线治疗鼻咽癌的新适应症上市申请获受理</title><link>https://mp.weixin.qq.com/s/-4rHoPXlqYkxd2fWM0QHlw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CXbhXUFE66H54gibz0BAZAfMDUuiaqQ0pThfxK84ftDIter7PPAUUEJkva3MxsFUGq7cvOcPDPnAVA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这是君实生物在鼻咽癌治疗领域递交的第二项新药上市申请。]]></content:encoded><pubDate>Thu, 18 Feb 2021 19:24:53 +0800</pubDate></item><item><title>浅谈药物共晶制备技术</title><link>https://mp.weixin.qq.com/s/1_-XVrrtgrjsTMqxt3STFA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CXbhXUFE66H54gibz0BAZAfmNBz8MqgPLzy4GsQ0ltrhRo0dB3h0cM0EWRLMEqLpL7uibHbR1xesqA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>​本文就药物共晶制备技术与筛选方法进行较为全面的论述。]]></content:encoded><pubDate>Thu, 18 Feb 2021 19:24:53 +0800</pubDate></item><item><title>已上市化学药品药学变更研究技术指导原则（试行）思维导向图</title><link>https://mp.weixin.qq.com/s/ZuGyGnV_nvL79FOgkWfBaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CXbhXUFE66H54gibz0BAZAfCw4F0R1C5KXrvZR6O7CS62Xg3DibgFPE24wvjaScoMKf3WVzVQok5TA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>归纳《已上市化学药品药学变更研究技术指导原则（试行）》。]]></content:encoded><pubDate>Thu, 18 Feb 2021 19:24:53 +0800</pubDate></item><item><title>萧柏明：我为什么要接受做同写意药学院院长？</title><link>https://mp.weixin.qq.com/s/s4NTHdzrjW5hE-vI4cisyA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AT5lsHMkso4ib6azGol6AIkj16CMwxCYicib0zC3yiaEP8XdyeV6AsNgP3Cu6o9zHFS2GzgJ9ll9ctoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>萧柏明：“同写意最大的特点是共同写意。”]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:24:19 +0800</pubDate></item><item><title>关注杜丨心衰患者福音！FDA批准诺华Entresto扩大适用范围</title><link>https://mp.weixin.qq.com/s/_nx0VU425CaxFeHCXB2niA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DlsjXiaiavC3tqPmwMyHHS6221KsfyxlksicH7D2SlrbmX0wtFGErzshgTFtX2fag8Tia8gLSaMwwC0Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>FDA首次批准治疗射血分数保留性心力衰竭的药物。]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:24:19 +0800</pubDate></item><item><title>安进与赛诺菲/再生元PCSK9专利战：看大药企如何“选边站”</title><link>https://mp.weixin.qq.com/s/8eNmKcPQfAU1d93cWwAnQQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DlsjXiaiavC3tqPmwMyHHS62X7EM6vQ7ukibuibxFGd1ogwTIcUN2cAHp6lx8KnxojQCUHPyT4DFibElw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>与该案无关的其它制药商们表达了相关立场。]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:24:19 +0800</pubDate></item><item><title>CAR-T细胞疗法全球专利格局，前20位只有一家中国公司上榜</title><link>https://mp.weixin.qq.com/s/1b7xPJY-hfWw1OCGecyxeg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DlsjXiaiavC3tqPmwMyHHS629ptUA0GLmGZhzFVd7wBibyDwRZCJaJEpoicHg7aCVk4BibYbxQovaSbuA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>前20名专利权人中只有一家中国公司——科济生物医药有限公司。]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:24:19 +0800</pubDate></item><item><title>多肽药物发现：未来趋势</title><link>https://mp.weixin.qq.com/s/yqnLDkS1XskS8W0g9dRqbQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DlsjXiaiavC3tqPmwMyHHS62lpRsdwgs0qfVzyCTMQiaJBmicUDJ1QyIB4KEnMISMiatAHyibXcsZbicjXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>肽药物发现和开发的主要趋势。]]></content:encoded><pubDate>Wed, 17 Feb 2021 17:24:19 +0800</pubDate></item></channel></rss>